ANNOUNCEMENT
INACTIVATION OF THE NHLBI SMALL GRANTS (R03) PROGRAM

National Heart, Lung, and Blood Institute
National Institutes of Health

Updated: May 2008

National Heart, Lung, and Blood Institute
http://www.nhlbi.nih.gov/index.htm

The National Heart, Lung, and Blood Institute (NHLBI) announces the inactivation of its Investigator-Initiated Small Grants (R03) Program effective immediately. Specifically, the Institute will not accept, review, or fund R03 applications for the November 1, 2001 receipt date and beyond.

The NHLBI Small Grants Program was intended to provide limited support in time and amount for research projects designed to analyze preexisting research data generated by clinical trials, population research, and demonstration and education grants.

The NHLBI may occassionally issue its own or participate in another IC's solicitations for small grant applications (R03) in the form of a Funding Opportunity Announcement (Request for Applications (RFA) or Program Announcements (PA)). A current example of such an announcement may be found at: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-08-008.html. Investigators wishing to apply for a small grant should also consider the R21 (Exploratory/Developmental Grants) mechanism.

Research investigators interested in obtaining funds for data analysis that heretofore would have been supported through the R03 mechanism are encouraged to contact the Institute to discuss currently available options.

INQUIRIES

For questions or further information, contact:

Paul A Velletri, Ph.D.
Director, Office of Extramural Policy and Review
Division of Extramural Research Activities
National Heart, Lung, and Blood Institute
Rockledge II, Room 7218
Bethesda, Maryland 20892-7922
Telephone: (301) 435-0569
FAX: (301) 480-4754
Email: VelletrP@nhlbi.nih.gov